Does the sun play a role in the aetiology of malignant melanoma? A review

South African Medical Journal

Volumn 97, Issue 8 PART 2, 2007, Pages 568-571

  Isaacson, Charles ^a   Ramsay, Michèle ^b  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

EUMELANIN; PHEOMELANIN; SUNSCREEN;

ALBINISM; CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER RISK; DEMOGRAPHY; ENVIRONMENTAL FACTOR; ETHNICITY; HEREDITY; HUMAN; MELANOMA; NEVUS; REVIEW; RISK FACTOR; SKIN CARCINOGENESIS; SUN EXPOSURE; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; SKIN TUMOR; ULTRAVIOLET RADIATION; BASAL CELL CARCINOMA; CANCER SUSCEPTIBILITY; NONHUMAN; SQUAMOUS CELL CARCINOMA;

HUMANS; MELANOMA; RISK FACTORS; SKIN NEOPLASMS; ULTRAVIOLET RAYS;

EID: 34548660553     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Schuster S. Melanoma and sun exposure (Letter). Lancet 1995; 346: 1224.
2. Whiteman DC, Brown RH, Purdie DM, Hughes MC. Melanocytic naesi in very young children: the role of phenotype, sun exposure, and sun protection. J Am Acad Dermatol 2005; 52: 40-47.
3. Harrison SL, Buettener PG, MacLennan R. The North Queensland 'Sun-Safe Clothing' Study: design and baseline results of a randomized trial to determine the effectiveness of sun-protective clothing in preventing melanocytic naevi. Am J Epidemiol 2005; 161: 536-545.
4. Dulon H, Weichenthal M, Blettner H, et al. Sun exposure and number of naevi in 5-6 year old European children. J Clin Epidemiol 2002; 55: 1075-1081.
5. Bauer J, Buttner P, Wiecker TS, Luther H, Garbe C. Risk factors of incident melanocytic naevi: a longitudinal study in a cohort of 1 232 young German children. Int J Cancer 2005; 115: 121-126.
6. Rafnsson V, Hrafnkelsson J, Tulinius H, Sigurgeirwson B, Olafsson JH. Risk factors for cutaneous malignant melanoma among air crews and a random sample of the population. Occup Environ Med 2003; 60: 815-820.
7. Kennedy C, Bajdik CD, Willemze R, De Gruijl FR, Bouwes Bavinck JN. Leiden Skin Cancer Study. The influence of painful sunburn and lifetime sun exposure on the risk of actinic keratoses, seborrhoeic warts, melanocytic naevi, atypical naevi, and skin cancer. J Invest Dermatol 2003; 120: 1087-1093.
8. Rivers JK. Is there more than one road to melanoma? Lancet 2004; 363: 728-730.
9. Garbe C, Orfanos CE. Epidemiology of malignant melanoma in central Europe: risk factors and prognostic predictors. Results of the Central Malignant Melanoma Registry of the German Dermatological Society. Pigment Cell Res 1992; Suppl 2, 285-294.
10. Christofers AJ. Melanoma is not caused by sunlight. Mutat Res 1998; 422: 113-117.
11. Isaacson C. Pathology of a Black African Population: Current Topics in Pathology. Heidelberg: Springer-Verlag, 1982.
12. Yakubu A, Mabogunje OA. Skin cancer in Zaria, Nigeria. Trop Doct 1995; 25: Suppl 1, 63-67.
13. Collins RJ. Melanoma in the Chinese of Hong Kong. Emphasis on volar and subungal sites. Cancer 1984; 54: 1482-1488.
14. Jimbow K, Takahashi H, Miura S, Ikeda S, Kukita A. Biological behaviour and natural course of acral malignant melanoma. Clinical and histologic features and prognosis of palmoplantar, subungual, and other acral malignant melanomas. Am J Dermatopathol 1984; 6 Suppl: 43-53.
15. Al-Maghrabi JA, Al-Ghamdi AS, Elhakeem HA. Pattern of skin cancer in Southwestern Saudi Arabia. Saudi Med J 2004; 25: 776-779.
16. Vijaykumar DK, Kanan RR, Chaturvedi HK. Plantar acral melanoma - an experience from a regional cancer centre, India. Indian J Cancer 1996; 33: 122-129.
17. Jaramillo-Ayerbe F, Vallejo-Contreras J. Frequency and clinical and dermatoscopic features of volar and ungual pigmented melanocytic lesions: a study in school children of Manizales, Colombia. Pediatr Dermatol 2004; 21: 218-222.
18. Ragnarsson-Olding BK. Primary malignant melanoma of the vulva - an aggressive tumour for modeling the genesis of non-UV light-associated melanomas. Acta Oncol 2004; 43: 421-435.
19. Gefeller O, Pfahlberg A. Sunscreen use and melanoma: a case of evidence-based prevention? Photodermatol Photoimmunol Photomed 2002; 18: 153-156.
20. Vainio H, Miller AB, Bianchini F. An international evaluation of cancer-preventative potential of sunscreens. Int J Cancer 2000; 88: 838-842.
21. Autier P, Dore JF, Cattaruzza MS. et al. Sunscreen use, wearing clothes, and number of naevi in 6-to 7-year old European children. European Organisation for Research and Treatment of Cancer Melanoma Co-operative Group. J Natl Cancer Inst 1998; 90: 1837-1880.
22. Chiang TM, Sayre RM, Dowdy JC, Wilkin NK, Rosenberg EW. Sunscreen ingredients inhibit inducible nitric oxide synthase (iNOS): a possible biochemical explanation for the sunscreen melanoma controversy. Melanoma Res 2005; 15: 3-6.
23. Bastuji-Garin S, Diepgen TL. Cutaneous malignant melanoma, sun exposure, and sunscreen use: epidemiological evidence. Br J Dermatol 2002; 61: 24-30.
24. Bigby ME. The end of the sunscreen and melanoma controversy. Arch Dermatol 2004; 140: 745-746.
25. Landow K. Do sunscreens prevent skin cancer? Postgrad Med 116: 3.
26. Ichihashi M, Ueda M, Budiyanto A, et al. UV-induced skin damage. Toxicology 2003; 189: 21-39.
27. Thody AJ, Higgins EM, Wakamatsu K, Ito S, Burchill SA, Marks JM. Phaeomelanin as well as eumelanin is present in human epidermis. J Invest Dermatol 1991; 97: 340-344.
28. van Nieuwpoort F, Smit NP, Kolb R, van der Meulen H, Koerten H, Pavel S. Tyrosine-induced melanogenesis shows differences in morphologic and melanogenic preferences of melanosomes from light and dark skin types. J Invest Dermatol 2004; 122: 1251-1255.
29. Pavel S, van Nieuwpoort F, van der Meulen H, et al. Disturbed melanin synthesis and chronic oxidative stress in dysplastic naevi. Eur J Cancer 2004; 40:1423-1430.
30. Salopek TG, Yamada K, Ito S, Jimbow K. Dysplastic melanocytic nevi contain high levels of pheomelanin: quantative comparison of phaeomelanin/eumelanin levels between normal skin, common nevi, and dysplastic nevi. Pigment Cell Res 1991; 4: 172-179.
31. Vincensi MR, Ischia M, Napolitano A, et al. Phaeomelanin versus eumelanin as a chemical indicator of ultraviolet sensitivity in fair-skinned subjects at high risk for melanoma: a pilot study. Melanoma Res 1998; 8: 53-58.
32. Saito N, Morishima T. Eumelanin and phaeomelanin contents in hairs of healthy Japanese patients with oculocutaneous albinism, and 5-S-cysteinyldopa and 5-hydroxy-6-methoxyindole-2-carboxylic acid levels in urine of oculocutaneous albinism. Nippon Hifuka Gakkai Zasshi 1990; 100: 853-861.
33. Kromberg JG, Castle D, Zwane EM, Jenkins T. Albinism and skin cancer in Southern Africa. Clin Genet 1989; 36: 43-52.
34. Yakubu A, Mabogunje OA. Skin cancer in African albinos. Acta Oncol 1993; 32: 621-622.
35. Pehamberger H, Honigsmann H, Wolff K. Dysplastic nevus syndrome with multiple primary amelanotic melanomas in oculocutaneous albinism. J Am Acad Dermatol 1984; 11: 731-735.
36. Ihn H, Nakamura K, Abe M, et al. Amelanotic metastatic melanoma in a patient with oculocutaneous albinism. J Am Acad Dermatol 1993; 28: 895-900.
37. Streutker CJ, McCready D, Jimbow K, From L. Malignant melanoma in a patient with oculocutaneous albinism. J Cutan Med Surg 2000; 4:149-152.
38. Bothwell JE. Pigmented skin lesions in tyrosinase-positive oculocutaneous albinos: a study in Black South Africans. Int J Dermatol 1997; 36: 831-836.
39. Wang LE, Xiong P, Strom SS, et al. In vitro sensitivity to ultraviolet B light and skin cancer risk: a case-control analysis. J Natl Cancer Inst 2005; 97: 1822-1831.
40. Kefford RF, Newton Bishop JA, Bergman W, Tucker MA. Counseling and DNA testing for individuals perceived lobe genetically predisposed to melanoma: A consensus statement of the Melanoma Genetics Consortium. J Clin Oncol 1999; 17: 3245-3251.
41. Masback A, Olsson H, Westerdahl J, et al. Clinical and histopathological features of malignant melanoma in germline CDKN2A mutation families. Melanoma Res 2002; 12: 549-557.
42. Palmer JS, Duffy DL, Box NF, et al. Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype? Am J Hum Genet 2000; 66: 176-186.
43. Landi MT, Kanetsky PA, Tsang S, et al. MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population. J Natl Cancer Inst 2005; 97: 998-1007.
44. Duffy DL, Box NF, Chen W, et al. Interactive effects of MC1R and OCA2 on melanoma risk phenotypes. Hum Mol Genet 2004; 13: 447-461.
45. Box NF, Duffy DL, Chest W, et al. MC1R genotype modifies risk of melanoma in families segregating CDKN2A mutations. Am J Hum Genet 2001; 69: 765-773.
46. Whiteman DC, Green AC. A risk prediction tool for melanoma? Cancer Epidemiol Biomarkers Prev 2005; 14: 761-763.
47. Bataille V, Bishop JA, Sasieni P, et al. Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study. Br J Cancer 1996; 73: 1605-1611.
48. Zhu G, Duffy DL, Eldridge A, et al. A major quantitative-trait locus for mole density is linked to the familial melanoma gene CDKN2A: a maximum-likelihood combined linkage and association analysis in twins and their sibs. Am J Hum Genet 1999; 65: 483-492.
49. Curtin JA, Fridlyand J, Kageshita T, et al. Distinct sets of genetic alterations in melanoma. N Engl J Med 2005; 353: 2135-2147.
50. Whiteman DC, Brown RM, Purdie DM, Hughes MC. Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma. J Natl Cancer Inst 2003; 95: 806-812.